Hyundai Motor Group Celebrates 20 Years of Driving Innovation at the Hyundai California Proving Ground
Milestone reaffirms Hyundai Motor Group's commitment to safety, quality, design, and performance More than 5,000 vehicles have been tested and driven more than 20-million miles at the facility since opening in 2005 20-year celebratory event and...
Restore Vision Announces First Patient Dosed in Phase I/II Clinical Trial of RV-001 for Gene-Agnostic Retinitis Pigmentosa
The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial. RV-001 a gene-agnostic approach for RP patients. TOKYO, Feb. 13, 2025 /PRNewswire/ -- Restore...
Aker Horizons ASA: Fourth-quarter results 2024
FORNEBU, Norway, Feb. 13, 2025 /PRNewswire/ -- Aker Horizons ASA (OSE: AKH), a developer of green energy and industry, today announced results for the fourth quarter 2024. Aker Horizons' net capital employed stood at NOK 5.9 billion, a decrease of...
Cloud4C Secures Dual AI Specializations on Microsoft Azure, Strengthening AI Capabilities
SINGAPORE, Feb. 13, 2025 /PRNewswire/ -- Cloud4C, a global leader in AI-driven cloud and cybersecurity services, has achieved two prestigious AI specializations on Microsoft Azure: 'AI Platform on Microsoft Azure' and 'Build AI Apps on Microsoft...
Hugel achieves record net sales, profit, net income in 2024
- The company reports KRW373.0 billion in net sales, KRW166.3 billion in operating profit, and KRW142.4 billion in net income, reflecting year-over-year increases of 16.7%, 41.2%, and 45.8%, respectively - More international revenue contributions to...
DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development
SEOUL, South Korea, Feb. 13, 2025 /PRNewswire/ -- DAAN Biotherapeutics, a leading innovative drug development company specializing in T-cell receptor (TCR)- based therapies, has signed an exclusive licensing agreement with LigaChem Biosciences for a...
Woolpert Welcomes Head of Strategic Growth, Asia-Pacific Susie Henderson
The accomplished global business executive will oversee the firm's strategic growth initiatives for the Asia-Pacific region. BRISBANE, Australia, Feb. 13, 2025 /PRNewswire/ -- Woolpert has hired Susie Henderson as Head of Strategic Growth,...
Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Ovarian Cancer of Anti-HER2 Bispecific ADC JSKN003
SUZHOU, China, Feb. 13, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-306) of anti-HER2 biparatopic antibody-drug...